HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 25 filers reported holding HEMISPHERX BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $74,000 | -11.9% | 462,003 | +0.3% | 0.00% | – |
| Q4 2018 | $84,000 | -20.0% | 460,608 | +0.4% | 0.00% | – |
| Q3 2018 | $105,000 | -28.1% | 458,919 | +0.1% | 0.00% | – |
| Q2 2018 | $146,000 | -19.3% | 458,448 | +0.2% | 0.00% | – |
| Q1 2018 | $181,000 | +13.1% | 457,380 | -1.1% | 0.00% | – |
| Q4 2017 | $160,000 | +7.4% | 462,603 | +0.2% | 0.00% | – |
| Q3 2017 | $149,000 | -35.2% | 461,895 | +0.3% | 0.00% | – |
| Q2 2017 | $230,000 | -14.5% | 460,698 | -6.7% | 0.00% | – |
| Q1 2017 | $269,000 | – | 493,946 | +1175961.9% | 0.00% | – |
| Q4 2016 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 15,834 | $6,000 | 0.00% |
| Virtu Financial LLC | 34,330 | $14,000 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 451,169 | $178,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| UBS Group AG | 1,714 | $1,000 | 0.00% |
| Well Done, LLC | 190 | $0 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |